The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global brain computer interface market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 12% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.
A brain computer interface (BCI) is a system used for acquiring, analyzing, and translating brain signals into commands using an artificial output device. This device assists in replacing, restoring, enhancing, supplementing, and improving the functions of the central nervous system (CNS). BCI replaces or restores the useful function of individuals suffering from neuromuscular disorders, such as cerebral palsy, amyotrophic lateral sclerosis, or spinal cord injury. It is also useful for rehabilitation after stroke or other disorders. As it finds extensive application in communicating and controlling patients with severe paralysis or in the locked-in syndrome (LIS), its demand is escalating around the world.
The rising geriatric population, coupled with the increasing prevalence of neurodegenerative disorders such as epilepsy and Alzheimer’s and Parkinson’s diseases, represents one of the key factors strengthening the growth of the market. Additionally, there is a rise in the integration of BCI technologies with several healthcare applications. This, in confluence with the increasing focus on using BCI technologies to control internet of things (IoT) devices and virtual reality (VR) applications, is propelling the market growth. Moreover, on account of its high accuracy and reliability and improved security monitoring, BCI technology finds application in controlling smart home applications and activities, such as opening and closing doors and windows and operating the television or music system. Furthermore, technological advancements in bio-sensing, nanotechnology, bio-signal processing, and neuro-imaging techniques, along with increasing investments in research and development (R&D) activities, are offering a positive outlook to the market. Besides this, the increasing adoption of BCI in the defense and military sector is anticipated to stimulate the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global brain computer interface market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product and application.
Breakup by Product:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Brain Monitoring Inc., ANT Neuro, Compumedics Limited, EMOTIV, Medtronic plc, Natus Medical Incorporated, NeuroSky Inc., Nihon Kohden Corporation and NIRx Medical Technologies LLC.
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Advanced Brain Monitoring Inc., ANT Neuro, Compumedics Limited, EMOTIV, Medtronic plc, Natus Medical Incorporated, NeuroSky Inc., Nihon Kohden Corporation and NIRx Medical Technologies LLC.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at